CGRP (SB)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCGRP (SB)
Drug Alias NamehCGRP (SB)calcitonin gene-related polypeptidecalcitonin peptide (SB)CGRP
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenylate cyclase stimulants
TargetsAdenylate cyclase
Therapy Area/IndicationsRaynaud DiseaseAngina PectorisHeart Failure +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSmithkline Beecham Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSmithkline Beecham Plc
Active IndicationsN/A
Inactive IndicationsRaynaud DiseaseAngina PectorisHeart Failure +[5] 

Other Information

ATC CodeN/A
Related LinksN/A